|
|
|
|
New Path To Therapeutic HIV Vaccine Discovered By Studying Immunologic Profile Of Rare HIV Controllers
Based on encouraging results from pre-clinical research, Bionor Immuno AS today announced intentions to take the therapeutic and potentially preventative HIV-vaccine candidate Vacc-C5 into a Phase I/II clinical trial.The research results indicate that Vacc...
|
|
|
New Path to Therapeutic HIV Vaccine Discovered by Studying Immunologic Profile of Rare HIV Controllers
SLO, NORWAYMARKETWIRE Based on encouraging results from pre-clinical research, Bionor Immuno AS today announced intentions to take the therapeutic and potentially preventative HIV-vaccine candidate Vacc-C5 into a Phase I/II clinical trial.The research...
|
|
|
New Path to Therapeutic HIV Vaccine Discovered by Studying Immunologic Profile of Rare HIV Controllers
OSLO, NORWAY -- (MARKET WIRE) -- 03/17/10 -- Based on encouraging results from pre-clinical research, Bionor Immuno AS today announced intentions to take the therapeutic and potentially preventative HIV-vaccine candidate Vacc-C5 into a Phase I/II clinical trial...
|
|
|
New Path to Therapeutic HIV Vaccine Discovered by Studying Immunologic Profile of Rare HIV Controllers
_ New Path to Therapeutic HIV Vaccine Discovered by Studying Immunologic Profile of Rare HIV Controllers.
|
|
|
Immunologic Abnormality of Intrahepatic Cholestasis of Pregnancy
Yayi H et al.In ICP, an increase of type 1 cytokine (TNFalpha, IFNgamma) associated with a decrease of type 2 cytokine (IL4). The decreased production of the suppressor cytokine TGFbeta2 may increase the type 1 cytokine. Fas appeared to be increased and...
|
|
|
Immunologic tolerance to the insulin analogue glulisine
In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.To find out how to adjust your browser settings to accept cookies, please click here. Medscape uses cookies to customize the site based on the information...
|
|
|
Starting HAART With High CD4 Counts Reduces Incidence of Squamous Cell Anal Cancer: Presented at CROI
-- Patients with HIV who begin antiretroviral therapy before their CD4-positive cell counts drop below 200 cells/mm3 appear to have significantly reduced risk of developing squamous cell cancer of the anus, researchers said here at the 17th Conference on...
|
|
|
Oncology Thought Leaders Assess Lead Compounds in Development for Ovarian Cancer
New analysis from MedPredict sheds light on most important advances in treatment of ovarian cancer -- there continues to be significant unmet need for effective therapies, especially in metastatic disease.(PRWEB) February 11, 2010 -- MedPredict Market...
|
